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Abstract  
BACKGROUND: It’s assumed that surgery in haemophilia can be accomplished these days safely. 
AIM: The aim of this study was to investigate the influence of new surgical technologies in the perioperative 
management and outcome of surgical procedures in haemophiliacs. 
METHODS: Two patients with mild haemophilia A underwent surgery (laparoscopic appendectomy and inguinal 
hernia repair). In both patients, the replacement therapy, with factor VIII, started 30 min before surgery. We used 
the available surgical technologies and techniques with a proven value in the best clinical practice, to achieve 
proper and permanent hemostasis. Postoperatively, the replacement therapy and thromboembolic prophylaxis 
was continued according to the international guidelines for the management of haemophilia. 
RESULTS: The operative and post-operative periods were uneventful. No significant differences were found in 
the operation time in our hemophilic patients versus non-hemophilic patients. Significant differences related to the 
hospital stay duration were found in both patients compared with controls, due to the necessary replacement 
therapy. 
CONCLUSION: With new surgical technologies, proper and permanent hemostasis can be achieved, without 
prolonging the operation time. 
 
 
 
 
 
 
Introduction 
 
A better understanding of the clotting 
mechanisms and the ability to manufacture factor 
concentrates have enabled the performance of more 
and major surgical procedures in hemophilic patients, 
even in patients with inhibitors [1-3]. It is assumed that 
surgery in haemophilia can be safely accomplished 
these days, if a specialised team approach, hospital 
capable of supporting intense factor concentrate use 
and timely laboratory monitoring are insured [4]. The 
surgical technique is the second most important part 
of the treatment of hemophilic patients and should 
provide proper and permanent hemostasis to prevent 
unnecessary blood loss, additional replacement 
therapy and to avoid postoperative wound healing 
complications. The conventional surgery preferred 
meticulous hemostasis using ligation for all visible 
bleeding and cautery only for capillary bleeding, at the 
same time trying to keep the operative time to a 
minimum [1, 5, 6]. Some surgeons recommend the 
use of topical hemostatic agents and fibrin sealants 
during orthopaedic procedures in patients with 
inhibitors [2], others recommend surgeons always to 
have fibrin glue and chitosan-based dressings by their 
side [7]. In the literature, there is a lack of data on the 
use of an advanced bipolar technology in surgical 
procedures in hemophilic patients. 
The aim of this study was to investigate the 
influence of new surgical technologies in the 
perioperative management and outcome of surgical 
procedures in haemophiliacs. 
 
 
Material and Methods 
 
Two patients with mild haemophilia A 
underwent surgery in our clinic. The first patient was a 
64-year-old male patient, with a history of painful 
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inguinal hernia and episodes of incarceration solved 
with taxis and a past history of hepatitis C. The 
second patient was a 46-year- old male patient, with a 
history and clinical findings of acute appendicitis from 
the previous day, sent to our clinic from the local 
hospital. Тhе planning and preoperative preparation 
was performed in collaboration with the treatment 
team from the National Center for Hemophilia. The 
preoperative factor VIII level was 20% in the first and 
15% in the second patient and the presence of an 
inhibitor was excluded. The desired preoperative 
factor VIII level was achieved with a 30 min. Infusion 
of factor VIII before surgery, according to the 
standardised formula. The postoperative plasma 
factor level and duration of administration were 
maintained according to the international guidelines 
for the management of haemophilia. In the 
postoperative period, thromboembolic prophylaxis 
with enoxaparin was given according to the laboratory 
test results. 
Incision of the skin, in both patients, was done 
with electrosurgery, needle electrode and pure cut 
mode. Incision of the subcutaneous tissue in the first 
patient was done with a Valleylab
TM mode, and any 
vascularized tissue and vessel, including 
subcutaneous tissue, cremaster muscle and hernia 
sac were dissected, sealed and cut with a LigaSure
TM 
5 mm instrument (ValleyLab, Inc., Covidien, 
Medtronic, Boulder, Colorado, USA). In the first 
patient, the inguinal hernia repair was performed 
according to the Lichtenstein technique. In the second 
patient, a laparoscopic access was obtained with 
three ports (5, 10 and 12 mm) of VersaStep
TM PLUS, 
a radially expandable access system (Covidien, 
Medtronic, Mansfield, MA, USA). Intraoperatively, a 
gangrenous appendicitis with a local peritonitis was 
found. The mesoappendix was dissected, sealed and 
cut with a LigaSure
TM 5 mm instrument. The 
confluence of the appendix and cecum was stapled 
with Endo GIA™ 30 mm reload with a Tri-Staple™ 
technology (Covidien, Medtronic, Mansfield, MA, 
USA). After a local lavage, an abdominal drain was 
inserted through a 12mm port access. During the 
operative period, blood loss, operative time and 
operative cost were measured. In the postoperative 
period, the plasma factor level, the presence of any 
sign of bleeding, other postoperative complications 
and overall cost of the replacement therapy were 
determined. 
 
 
Results 
 
The operative period was uneventful. We did 
not notice any bleeding during both procedures; we 
even had the impression that the achieved 
hemostasis was better than in non-hemophilic 
patients. The operative time, from incision to skin 
closure, was 60 min for the hernia repair, and 45 min 
for the laparoscopic appendectomy. The extra 
operative cost for the inguinal repair was 445 Euros 
(LigaSure
TM 
5 mm instrument) and 922 Euros for the 
laparoscopic appendectomy (LigaSure
TM 5 mm and 
Endo GIA™ instrument and cartridge). 
Table 1: Postoperative factor VIII plasma level 
 
Major surgery 
desired level % 
of normal [13] 
Postoperative factor VIII plasma level 
Post op day 1-3 
60–80 
Post op day 4-6 
40–60 
Post op day 7-14 
30–50 
Achieved level Post op day 1 Post op day 4 Post op day 8 Post op day 11 
Hernioplasty 68% 80% 74% 65% 
Appendectomy 99% 105% 92% 50% 
 
The postoperative period was also uneventful. 
The postoperative factor plasma level is shown in 
Table 1. The overall cost for the 14-day treatment with 
a replacement therapy for the patient with an inguinal 
hernia was 5361 Euros, while for the second patient it 
was 5929 Euros. The postoperative hospital stay was 
8 days, after which both patients received a 
replacement therapy in the outpatient department. 
 
 
Discussion 
 
Surgery in patients with haemophilia requires 
a specialised team approach and a hospital capable 
of supporting intense factor concentrate use and 
timely laboratory monitoring. The optimal approach 
utilises the coordination and resources of the 
comprehensive Hemophilia Treatment Center team 
working closely with the surgeon and anesthesiologist 
[4]. The surgical team should use a surgical technique 
which will ensure proper and permanent hemostasis 
to prevent unnecessary blood loss without extending 
the operating time at the same time. We are 
committed to using the available surgical technologies 
and techniques with a proven value in the best clinical 
practice for all of our patients if their use is cost-
effective. Our extensive experience in using an 
advanced bipolar technology and electrosurgery 
during major open and advanced laparoscopic 
procedures, enable us to feel safe and secure when 
applying these technologies in haemophiliacs [8]. 
Current evidence suggests that skin incisions with 
electrosurgery are quicker and associated with less 
blood loss than those made with a scalpel, and there 
are no differences in the rate of wound complications 
or postoperative pain [9, 10]. We routinely use this 
technique in all our patients, including the two patient 
with haemophilia. We do not use enhanced 
LigaSure
TM tissue fusion technology for hernioplasty 
and appendectomy routinely in non-hemophilic 
patients because it is not cost-effective, but these 
procedures are defined аs major procedures in 
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haemophiliacs because they require hemostatic 
support for periods exceeding 5 consecutive days 
[11]. Current evidence suggests that the use of this 
technology can be achieved safely by sealing a 
variety of thoracic and anterior abdominal wall tissues 
with an injury and leakage profile comparable to the 
established technologies [12]. So, if using this 
technology, the ultimate goal of preventing blood loss 
and additional replacement therapy in haemophiliacs 
is achieved, the use of expensive instruments will be 
justified. Our results show that we achieved proper 
and permanent hemostasis. Furthermore, with a 
standardised replacement therapy, the postoperative 
factor VIII plasma level was above the recommended 
level [13]. Perhaps, this difference between the 
desired and achieved plasma factor VIII level was the 
result of our transfusiologist’s precaution and her 
previous experience with the conventional surgery. 
Laparoscopic procedures are contraindicated 
in patients with an uncorrectable coagulopathy, but 
whether a laparoscopic or conventional surgery 
should be recommended in hemophilic patients is still 
a controversial question [14, 15]. We preferred an 
individual approach for the treatment of our patients. 
Our experience with thrombocytopenic patients, 
during laparoscopic splenectomy for ITP, has shown 
that it is essential to prevent unnecessary damage to 
the abdominal wall when providing access ports and 
using methods for hemostasis independent of the 
coagulation and fibrinolytic processes [16, 17]. It 
justifies the use of a laparoscopic access in our 
patients with a radially expandable access system, 
and an abdominal drain inserted through a port 
access, and at the same time achieving hemostasis 
with the LigaSure
TM and Endo GIA™ Tri-Staple™ 
technologies. 
Compared with the operative time for non-
hemophilic patients, the operative time for our patients 
was longer but not significantly. In the study of Lingohr 
at al., no significant differences were found in the 
duration of surgery and drained in laparoscopically or 
conventionally operated haemophiliacs versus 
matched pairs [15]. On the other hand, the 
postoperative hospital stay of our patients, compared 
with non-hemophilic patients, was longer due to the 
replacement therapy. A prolonged hospital stay in 
haemophiliacs was also found in the study of 
Goldmann at al. [18] and Coppola at al. [19]. In the 
study of Lingohr at al., a significantly shorter hospital 
stay was achieved in haemophiliacs treated with 
laparoscopic vs. conventional procedures resulting in 
reduced therapeutic costs and a faster mobilisation 
[15]. 
The overall cost of the treatment for 
haemophiliacs is high, mostly due to the necessary 
replacement therapy or because of postoperative 
complications [1,18-20]. In our cases, the extra 
operative cost was 8.5% and 15.5% respectively from 
the total cost of the replacement therapy. In the 
postoperative period, there were no complications or 
need for additional therapy, since in the both patients 
the achieved factor VIII levels were above predefined 
target ranges as stated by the international guidelines 
[13]. Karaman at al. in their study confirmed that 
electrocautery with a direct current is a safe and long-
term reliable method for hemostasis during 
circumcision in bleeding disorders and can be used 
with an updated factor replacement protocol with a 
lower cost and approximately the same complication 
rates [6]. The efficiency and safety of the enhanced 
LigaSure
TM tissue fusion technology in providing 
proper and permanent hemostasis with reduction of 
the operating time has been demonstrated in many 
studies [12, 16, 21, 22]. The achieved hemostasis with 
the tissue fusion technology is permanent and 
exceeds the time required for satisfactory healing of 
surgical wounds of 2-3 weeks after surgery [23]. In 
future, the conclusion of Hazendonk at al. that the 
quality of care and cost-effectiveness of perioperative 
treatment of haemophilia A patients can be upgraded 
by refining the dosing strategies based not only on 
individual patient characteristics and mode of infusion 
but the basis of the applied technique for surgical 
hemostasis as well. Our opinion is supported by the 
results of Karaman at al. and Aryal et al. [25]. Aryal et 
al. which indicate that postoperative hemorrhagic 
complications in no case were attributable to 
inadequate factor replacement. 
Оur experience in the treatment of 
hemophilics is modest, but we have applied the 
above-mentioned techniques in non-hemophilic 
patients and patients with impaired hemostasis due to 
thrombocytopenia with very good results. In both 
patients, we avoided the use of contact and sprayed 
coagulation with a conventional electrosurgery. The 
results of the treatment achieved in both hemophilic 
patients showed that our approach was justified. 
In conclusion, with new surgical technologies, 
proper and permanent hemostasis can be achieved, 
without prolonging the operation time. New surgical 
technologies facilitate surgical hemostasis and 
surgery in hemophilic patients, but further studies are 
needed to select the best clinical practice. 
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